Related Experiment Videos
Androgens in pubertal males with Addison's disease
The Journal of Clinical Endocrinology and Metabolism
|October 1, 1980
Summary
Puberty onset in males with Addison's disease is similar to healthy boys. Steroid hormone levels reveal testosterone is primarily testicular, while dehydroepiandrosterone is mainly adrenal in origin.
Area of Science:
- Endocrinology
- Pediatric Endocrinology
- Reproductive Medicine
Background:
- Addison's disease is a rare endocrine disorder affecting the adrenal glands.
- Pubertal development timing is crucial for long-term health and requires proper adrenal and gonadal function.
- Understanding steroidogenesis in conditions like Addison's disease is vital for managing patients.
Purpose of the Study:
- To investigate the timing of pubertal onset in male patients with Addison's disease.
- To analyze the origin of key steroid hormones during puberty in males with and without Addison's disease.
- To compare steroid profiles between different patient groups.
Main Methods:
- Documented pubertal development in seven male patients with Addison's disease.
- Excluded patients with pre-pubertal autoimmune complications.
- Measured integrated plasma levels of testosterone, androstenedione, 17-hydroxyprogesterone, progesterone, and dehydroepiandrosterone.
- Compared results with agonadal males, normal adult males, and pubertal boys.
Main Results:
- The mean age of pubertal onset in five male Addison's patients was 12.3 years, comparable to normal American boys (11.4 years).
- Testosterone was confirmed as primarily testicular in origin.
- Dehydroepiandrosterone was found to be mainly of adrenal origin.
- Androstenedione and 17-hydroxyprogesterone showed contributions from both testicular and adrenal sources.
Conclusions:
- Male patients with Addison's disease experience normal pubertal timing.
- Adrenal insufficiency does not significantly alter the onset of puberty in males.
- Steroid hormone profiling confirms distinct origins for testosterone and dehydroepiandrosterone, with mixed origins for androstenedione and 17-hydroxyprogesterone.